Drugs / BEBT-701
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07368608 | Jan 2026 → Nov 2028 expected | low density lipoprotein cholesterol, mild elevation of | BeBetter Med Inc | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BEBT-701 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07368608 ↗ |
| Route | Subcutaneous | “BEBT-701 injection administered subcutaneously on Day 1 and Day 85.” NCT07368608 ↗ |